An Explorative Note on Apraxia Tests by Philipp Gulde, Katharina Leippold, Alan Armstrong, Sarah Kohl, Timo Grimmer, Janine Diehl-Schmid, Joachim Hermsdörfer

Get full text

Step by Step: Kinematics of the Reciprocal Trail Making Task Predict Slowness of Activities of Daily Living Performance in Alzheimer’s Disease by Philipp Gulde, Katharina Leippold, Sarah Kohl, Timo Grimmer, Janine Diehl-Schmid, Alan Armstrong, Joachim Hermsdörfer

Get full text

Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers by Paul Theo Zebhauser, Achim Berthele, Oliver Goldhardt, Janine Diehl-Schmid, Josef Priller, Marion Ortner, Timo Grimmer

Get full text

The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort by Michaela Amft, Marion Ortner, Udo Eichenlaub, Oliver Goldhardt, Janine Diehl-Schmid, Dennis M. Hedderich, Igor Yakushev, Timo Grimmer

Get full text

Altered neurovascular coupling as measured by optical imaging: a biomarker for Alzheimer’s disease by Konstantin Kotliar, Christine Hauser, Marion Ortner, Claudia Muggenthaler, Janine Diehl-Schmid, Susanne Angermann, Alexander Hapfelmeier, Christoph Schmaderer, Timo Grimmer

Get full text

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease by Marion Ortner, René Drost, Dennis Heddderich, Oliver Goldhardt, Felix Müller-Sarnowski, Janine Diehl-Schmid, Hans Förstl, Igor Yakushev, Timo Grimmer

Get full text

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET by Oliver Goldhardt, Inanna Warnhoff, Igor Yakushev, Ilijana Begcevic, Hans Förstl, Viktor Magdolen, Antoninus Soosaipillai, Eleftherios Diamandis, Panagiotis Alexopoulos, Timo Grimmer

Get full text

Resting-State Connectivity of the Left Frontal Cortex to the Default Mode and Dorsal Attention Network Supports Reserve in Mild Cognitive Impairment by Nicolai Franzmeier, Jens Göttler, Jens Göttler, Timo Grimmer, Timo Grimmer, Alexander Drzezga, Alexander Drzezga, Miguel A. Áraque-Caballero, Lee Simon-Vermot, Alexander N. W. Taylor, Katharina Bürger, Katharina Bürger, Cihan Catak, Daniel Janowitz, Claudia Müller, Marco Duering, Christian Sorg, Christian Sorg, Christian Sorg, Michael Ewers

Get full text

An augmented reality approach for ADL support in Alzheimer’s disease: a crossover trial by Nina Rohrbach, Philipp Gulde, Alan Robert Armstrong, Linda Hartig, Anas Abdelrazeq, Stefan Schröder, Johanne Neuse, Timo Grimmer, Janine Diehl-Schmid, Joachim Hermsdörfer

Get full text

Biomarker Testing: Piercing the Fog of Alzheimer’s and Related Dementia by Denis Horgan, Flavio Nobili, Charlotte Teunissen, Timo Grimmer, Dinko Mitrecic, Laurence Ris, Zvezdan Pirtosek, Chiara Bernini, Antonio Federico, Daniel Blackburn, Giancarlo Logroscino, Nikos Scarmeas

Get full text

LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo by Timo Grimmer, Oliver Goldhardt, Liang-Hao Guo, Behrooz H. Yousefi, Stefan Förster, Alexander Drzezga, Christian Sorg, Panagiotis Alexopoulos, Hans Förstl, Alexander Kurz, Robert Perneczky

Get full text

Impact of normative brain volume reports on the diagnosis of neurodegenerative dementia disorders in neuroradiology: A real-world, clinical practice study by Dennis M. Hedderich, Benita Schmitz-Koep, Madeleine Schuberth, Vivian Schultz, Sarah J. Schlaeger, David Schinz, Christian Rubbert, Julian Caspers, Claus Zimmer, Timo Grimmer, Igor Yakushev

Get full text

Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening. by Susanne Angermann, Marcus Baumann, Dominik Steubl, Georg Lorenz, Christine Hauser, Yana Suttmann, Anna-Lena Reichelt, Robin Satanovskij, Franziska Sonntag, Uwe Heemann, Timo Grimmer, Christoph Schmaderer

Get full text

Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI by Stefan J. Teipel, Alexandra Wohlert, Coraline Metzger, Timo Grimmer, Christian Sorg, Michael Ewers, Eva Meisenzahl, Stefan Klöppel, Viola Borchardt, Michel J. Grothe, Martin Walter, Martin Dyrba

Get full text

Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels by Marion Ortner, Marion Stange, Heike Schneider, Charlotte Schroeder, Katharina Buerger, Katharina Buerger, Claudia Müller, Bianca Dorn, Oliver Goldhardt, Janine Diehl-Schmid, Hans Förstl, Werner Steimer, Timo Grimmer

Get full text

Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer’s Disease by Dennis M. Hedderich, Dennis M. Hedderich, René Drost, Oliver Goldhardt, Marion Ortner, Felix Müller-Sarnowski, Janine Diehl-Schmid, Claus Zimmer, Hans Förstl, Igor Yakushev, Igor Yakushev, Thomas Jahn, Timo Grimmer

Get full text

Cognitive impairment and microvascular function in end‐stage renal disease by Susanne Angermann, Roman Günthner, Henner Hanssen, Georg Lorenz, Matthias C. Braunisch, Dominik Steubl, Julia Matschkal, Stephan Kemmner, Renate Hausinger, Zenonas Block, Bernhard Haller, Uwe Heemann, Konstantin Kotliar, Timo Grimmer, Christoph Schmaderer

Get full text

Intepirdine as adjunctive therapy to donepezil for mild‐to‐moderate Alzheimer's disease: A randomized, placebo‐controlled, phase 3 clinical trial (MINDSET) by Frederick M. Lang, Yi Mo, Marwan Sabbagh, Paul Solomon, Merce Boada, Roy W. Jones, Giovanni B. Frisoni, Timo Grimmer, Bruno Dubois, Mark Harnett, Sarah R. Friedhoff, Shari Coslett, Jeffrey L. Cummings

Get full text

A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia by Amir Nazem, Chris C. Tang, Phoebe Spetsieris, Christian Dresel, Marc L. Gordon, Janine Diehl‐Schmid, Timo Grimmer, Igor Yakushev, Paul J. Mattis, Yilong Ma, Vijay Dhawan, David Eidelberg, Alzheimer's Disease Neuroimaging Initiative

Get full text

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study by Philip Scheltens, Merja Hallikainen, Timo Grimmer, Thomas Duning, Alida A Gouw, Charlotte E Teunissen, Alle Meije Wink, Paul Maruff, John Harrison, Caroline M van Baal, Suzanne Bruins, Inge Lues, Niels D Prins

Get full text